Document is current
Any future updates will be listed below
-
Authors
Bonifacio, Massimiliano
Maheshwari, Vikalp
Tran, Diana https://orcid.org/0000-0002-4207-7554
Agostoni, Gianluca
Filioussi, Kalitsa
Viana, Ricardo
-
Funding
Funding for this research was provided by:
Novartis Pharma AG
- License Information
-
More Information
Article History
Accepted: 24 June 2021
First Online: 23 July 2021
Declarations
:
: Support for the conduct and reporting of this study was provided by Novartis Pharma AG.
: The following authors are employed by the sponsor: Vikalp Maheshwari, Gianluca Agostoni, Kalitsa Filioussi, and Ricardo Viana. Massimiliano Bonifacio receives personal fees and non-financial support from the sponsor outside the submitted work. Diana Tran is an employee of EVERSANA, which received funding from Novartis Pharmaceuticals to develop the model described in this manuscript.
: Not applicable.
: Not applicable.
: The data, model, and methodology used in the research are proprietary.
: The programming code in the model used in the research is proprietary.
: VM, DT, and RV contributed to the concept and design. VM and GA contributed to the acquisition of data. MB, VM, GA, KF, and RV contributed to the analysis and interpretation of data. MB, VM, DT, GA, KF, and RV contributed to the drafting and review of the manuscript. RV contributed to the funding and supervision of the study.
